THROMBOEMBOLIC EVENTS POST CYTOREDUCTIVE SURGERY IN PATIENTS WITH OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER

被引：0
|
作者：
Atallah, D. [1 ]
Farraj, K. Abi [1 ]
Moubarak, M. [1 ]
El Kassis, N. [1 ]
Chahine, G. [2 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Obstet & Gynecol, Beirut, Lebanon
[2] St Joseph Univ, Hotel Dieu France Univ Hosp, Oncol, Beirut, Lebanon
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP933
引用
收藏
页码：A500 / A500
页数：1
相关论文
共 50 条
  • [41] IMPACT OF EXTENT OF CYTOREDUCTIVE SURGERY (CRS) ON SURVIVAL IN EPITHELIAL OVARIAN CANCER (EOC), PRIMARY PERITONEAL CARCINOMATOSIS (PPC), AND FALLOPIAN TUBE CANCER (FTC) AT THE AMERICAN UNIVERSITY OF BEIRUT (AUBMC)
    Seoud, M.
    El Housheimi, A.
    Jaafar, I.
    Hamed, K.
    Jamali, F.
    Abdallah, R.
    Khalil, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A138 - A138
  • [42] Surgical site infection after cytoreductive surgery in patients with ovarian, fallopian tube and primary peritoneal cancer, is an independent predictor of poor overall survival via significant delays in adjuvant chemotherapy
    Lee, Yeo-Jin
    Lee, Eun-Ju
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (06) : 20 - 28
  • [43] Management of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
    Liu, Joyce F.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5):
  • [44] A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian or primary peritoneal cancer
    Gerardi, M. A.
    Santillan, A.
    Meisner, B.
    Diaz-Montes, T. P.
    Gardner, G. J.
    Giuntoli, R. L., II
    Bristow, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer
    Rimel, B. J.
    Dockery, Lauren
    Randall, Leslie M.
    Moore, Kathleen
    FUTURE ONCOLOGY, 2020, 16 (33) : 2701 - 2711
  • [46] Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer
    Black, Destin
    Iasonos, Alexia
    Ahmed, Hina
    Chi, Dennis S.
    Barakat, Richard R.
    Abu-Rustum, Nadeem R.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (01) : 66 - 70
  • [47] MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA
    Gao, Yunong
    ANTICANCER RESEARCH, 2015, 35 (07) : 4301 - 4302
  • [48] BEVACIZUMAB IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER: A SINGLE CENTRE EXPERIENCE
    Ngu, S. F.
    Chan, K.
    Tse, K. Y.
    Chu, M.
    Ngan, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1611 - 1611
  • [49] Oral cyclophosphamide plus bevacizumab in recurrent ovarian, fallopian tube and primary peritoneal cancer
    Eyada, Mostafa
    Michael, Victoria
    Fellman, Bryan M.
    Patel, Shrina
    Soliman, Pamela T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Sood, Anil K.
    Westin, Shannon Neville
    Sims, Travis T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
    Acs, Miklos
    Herold, Zoltan
    Szasz, Attila Marcell
    Mayr, Max
    Haeusler, Sebastian
    Piso, Pompiliu
    CANCERS, 2022, 14 (14)
12345